abbvie-logo-grey
My_BloodLogo

This website has been funded and developed by AbbVie and is intended for Irish audiences only.

  • Home
  • Venclyxto® with obinutuzimab
  • Venclyxto® with rituximab
  • Venclyxto® by itself
  • FAST Facts
  • Patient Support Groups
Welcome_Hero

 

Welcome to My Blood and Me

 

Explore resources and information designed to support patients and carers in starting your CLL treatment.
To learn more, simply click on the button that corresponds to the treatment you've been prescribed.

Venclyxto with Obinutuzumab
Learn more
Venclyxto with Ritixumab
Learn more
Venclyxto by itself
Learn more
Patient Support Groups
Learn more

 

 Date of preparation: November 2024 | IE-VNCCLL-240043


Reporting of side effects - If you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly to the Health Products Regulatory Authority (HPRA) Pharmacovigilance department at www.hpra.ie. By reporting side effects, you can help provide more information on the safety of medicines.


This website has been funded and developed by AbbVie and is intended for Irish audiences only.

Copyright © 2024 AbbVie Limited. All rights reserved.

Registered Number: 510846. Ireland.

Terms of use
Privacy Policy

Information placed on this digital platform is not intended as a substitute for consultation with your healthcare professional.

AbbVie Ireland: 14 Riverwalk, Citywest Business Campus, Dublin 24, D24 XN32, Ireland.

Tel (0) 1 4287900 | www.abbvie.ie


©2025 All Rights reserved

AbbViePro Logo 2023

Welcome

To direct you to the most appropriate information, please confirm:

I am a patient currently receiving Venclyxto® (Venetoclax) as treatment for CLL.

By entering this website, you are confirming you are currently receiving Venclyxto® (Venetoclax) as treatment for CLL.

Information placed on this digital platform is not intended as a substitute for consultation with your healthcare professional.

Accept
I am not a patient currently receiving Venclyxto® (Venetoclax) as treatment for CLL.
Decline

Leaving Site

You are now leaving the My Blood and Me website and being re-directed to a site not controlled by AbbVie. AbbVie takes no responsibility for the content of any website owned and maintained by a third party. Do you wish to leave this site?

No
Yes
  • https://preview.mybloodandme.ie/
  • https://www.mybloodandme.ie/
  • prod.mybloodandme.ie
  • prod-preview.mybloodandme.ie